Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ITGB3 shows genetic and expression interaction with SLC6A4.

Lauren A Weiss1, Carole Ober, Edwin H Cook

  • 1Department of Human Genetics, The University of Chicago, Chicago, IL 60637, USA. laweiss@chgr.mgh.harvard.edu

Human Genetics
|May 25, 2006
PubMed
Summary

Genetic variations in the integrin beta3 (ITGB3) gene may influence autism risk by affecting serotonin transporter (SLC6A4) gene expression. ITGB3 and SLC6A4 may interact to impact autism susceptibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-GWAS Variant-to-Function Challenges in Asthma Research.

The Journal of allergy and clinical immunology·2026
Same author

Cumulative genetic risk for asthma contributes to disease severity in children with asthma.

The journal of allergy and clinical immunology. Global·2026
Same author

Epigenetic gestational age acceleration in cord blood is associated with activated inflammatory gene pathways and childhood asthma.

The Journal of allergy and clinical immunology·2026
Same author

Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk.

The Journal of allergy and clinical immunology·2026
Same author

S-PrediXcan predicted gene expression in human placenta is associated with childhood-onset asthma risk.

Scientific reports·2026
Same author

The association of newborn metabolites with early-life wheezing and asthma among US children in the ECHO Program.

Communications medicine·2026

Area of Science:

  • Neurogenetics
  • Molecular Psychiatry
  • Autism Spectrum Disorder Research

Background:

  • Autism spectrum disorder (ASD) shows a male predominance and is linked to serotonin system dysregulation.
  • The integrin beta3 (ITGB3) and serotonin transporter (SLC6A4) genes are implicated, identified as male quantitative trait loci for serotonin levels and associated with ASD.
  • Understanding the genetic mechanisms underlying these associations is crucial for identifying ASD risk factors.

Purpose of the Study:

  • To investigate if gene expression regulation mediates the association between serotonin levels and noncoding variations in the ITGB3 gene.
  • To explore potential interactions between ITGB3 and SLC6A4 in contributing to autism susceptibility.

Main Methods:

  • Analysis of publicly available murine and human expression data to assess ITGB3 and SLC6A4 expression correlation.

Related Experiment Videos

  • Examination of genetic variation in ITGB3 and its association with the expression of ITGB3 and SLC6A4 in unrelated CEPH individuals.
  • Statistical analysis to evaluate potential gene-gene interactions between ITGB3 and SLC6A4 genotypes in relation to autism susceptibility.

    • Main Results:

    • ITGB3 and SLC6A4 expression levels were found to be significantly correlated in both murine and human datasets (0.38
    • Genetic variations within the ITGB3 gene were significantly associated with the expression levels of both ITGB3 (P=0.012) and SLC6A4 (P=0.008).
    • Preliminary evidence suggests a significant interaction between genotypes at the ITGB3 and SLC6A4 loci in influencing autism susceptibility (P=0.033).

    Conclusions:

    • Regulation of gene expression, specifically how genetic variation in ITGB3 affects ITGB3 and SLC6A4 expression, may be a key mechanism linking serotonin system disturbances to autism.
    • The findings suggest a potential gene-gene interaction between ITGB3 and SLC6A4 that could contribute to the genetic architecture of autism spectrum disorder.
    • Further research is warranted to elucidate the precise molecular mechanisms and clinical implications of these genetic associations in autism.